Seeing Is Believing
BCTX is currently covered by 1 analysts with an average price target of $29.83. This is a potential upside of $26.65 (838.05%) from yesterday's end of day stock price of $3.18.
Briacell Therapeutics Corp's activity chart (see below) currently has 2 price targets and 14 ratings on display. The stock rating distribution of BCTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 78.57% with an average time for these price targets to be met of 191 days.
Highest price target for BCTX is $32, Lowest price target is $32, average price target is $32.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 22-Apr-2025. First documented stock forecast 14-Feb-2022.
Currently out of the existing stock ratings of BCTX, 12 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$32
$28 (700.00%)
$15
17 days ago
(22-Apr-2025)
11/14 (78.57%)
$26.65 (498.13%)
191
What is BCTX (Briacell Therapeutics Corp) average time for price targets to be met?
Which analyst has the current highest performing score on BCTX (Briacell Therapeutics Corp) with a proven track record?
Which analyst has the most public recommendations on BCTX (Briacell Therapeutics Corp)?
Which analyst is the currently most bullish on BCTX (Briacell Therapeutics Corp)?